BioCentury
ARTICLE | Company News

VLTS licenses GeneSwitch to Lexicon

August 1, 2001 7:00 AM UTC

Valentis granted LEXG a non-exclusive license to its GeneSwitch gene regulation technology for research purposes only in functional genomics in exchange for an upfront payment and maintenance fees. VL...